The Cardiovascular Health Study (CHS), a populationbased prospective cohort study, has been used to identify major risk factors associated with cardiovascular disease and stroke in the elderly. Objective: To assess the external validity of the CHS. Research Design: Comparison of the CHS cohort to a national cohort of Medicare beneficiaries and to Medicare beneficiaries residing in the CHS geographic regions. Subjects: CHS participants and a 5% sample of Medicare beneficiaries. Measures: Demographic and administrative characteristics, comorbid conditions, resource use, and mortality. Results: Compared with both Medicare cohorts, the CHS cohort was older and included more men and African American participants. CHS participants were more likely to be enrolled in Medicare managed care than beneficiaries in the national Medicare cohort. Compared with the Medicare cohorts, mortality in the CHS was more than 40% lower at 1 year, approximately 25% lower at 5 years, and approximately 15% lower at 10 years. There were minimal differences in comorbid conditions and health care resource use.
P opulation-based, prospective cohort studies are important for answering epidemiologic questions about the development of disease. They can track individuals without disease over time, establish a sequence of events before disease develops, measure multiple exposures of interest in a standardized fashion, and observe several outcomes in great detail. To minimize costs and increase efficiency, participants in prospective cohort studies are often recruited based on accessibility, such as geographic region. 1 The advantage of geographic restriction must be weighed against the disadvantage of limiting the representativeness of the sample and the generalizability to the entire population.
The Cardiovascular Health Study (CHS) is a population-based, prospective cohort study of persons aged 65 and older. 2 The CHS has identified major risk factors and physiologic processes associated with the onset and progression of cardiovascular disease and stroke in the elderly. [3] [4] [5] [6] [7] [8] [9] [10] Although the internal validity of the CHS has been examined previously, 11 the external validity of the CHS has not been assessed. In this study, we sought to determine whether the CHS is representative of Medicare beneficiaries nationally and of Medicare beneficiaries residing in the geographic regions sampled by the CHS. Specifically, we examined whether the CHS cohort was comparable with 2 Medicare cohorts at baseline with regard to patient characteristics, comorbid conditions, and resource use and as measured by mortality at 10 years.
METHODS

Data Sources
Participants in the CHS were randomly sampled from the Medicare eligibility list of the Health Care Financing Administration, now the Centers for Medicare and Medicaid Services (CMS). Detailed methods for identifying and recruiting participants into the CHS have been described elsewhere. 12 In brief, 5888 participants aged 65 years and older were recruited from 4 geographic regions: Forsyth County, North Carolina; Sacramento County, California; Washington County, Maryland; and Pittsburgh, Pennsylvania. 13 Individuals were excluded from the CHS cohort if they were "institutionalized (including nursing homes), in a hospice program or under active treatment for cancer . . . , were confined to a wheelchair in the home, were cognitively unable to sign an informed consent, or did not expect to remain in the community for 3 years." 13 Individuals were also excluded if they required a proxy respondent at the baseline interview. In addition to individuals randomly sampled from the Medicare eligibility list, those who were aged 65 years or older and were living in the same household were also recruited to participate if they met the inclusion criteria. 12 Recruitment of the first cohort began in 1989 and was completed in 1990. Of the 11,955 individuals sampled during the first recruitment phase, 1062 were ineligible and 5201 were enrolled. 12 Recruitment of a second cohort comprising African American beneficiaries began in 1992 and was completed in 1993. A total of 687 African American participants were enrolled during the second recruitment phase. 13 Once enrolled, participants were contacted semiannually through 1999 in encounters that alternated between clinic examinations and telephone follow-up, where information about cardiovascular events, changes in risk factors and functional status, and hospitalizations was collected.
14 Since 1999, the CHS has continued to follow participants with semiannual telephone calls. 2 Medicare is the largest purchaser of health care and provides insurance to nearly 40 million elderly Americans. 15 Medicare Part A provides coverage for inpatient care provided in hospitals, short-term stays in skilled nursing facilities, hospice care, and Postacute home health care. Medicare Part B provides coverage for outpatient services, including physician visits and other medical services, outpatient hospital care, and some preventive services. The Medicaid program provides free or low-cost health care coverage for low-income Americans, including Medicare beneficiaries. 16 For this study, we obtained from CMS all Medicare Part A inpatient claims, all Medicare Part B outpatient and physician/carrier claims, and the corresponding denominator files for CHS participants. The denominator files include beneficiary identifiers, dates of birth, sex, race/ethnicity, dates of death, and information about program eligibility and enrollment. Information in the denominator files is received annually, even if no claims were generated in a given year. CMS selected matching claims for CHS participants on the basis of Social Security number, birth date, and sex. For purposes of comparison, we also obtained CMS claims data and denominator files for a 5% sample of Medicare beneficiaries from 1992 forward. The 5% sample is a systematic, quasirandom sample constructed by CMS using 2-digit combinations from beneficiaries' health insurance claim number. 17 This study was approved by the institutional review board of the Duke University Health System.
Study Population
We created 2 Medicare cohorts retrospectively from the Medicare 5% sample (Fig. 1) . The first was a national cohort of beneficiaries aged 65 years or older on January 1, 1993. We excluded beneficiaries who were not living in the United States and beneficiaries identified as participants in the CHS. The second was a regional cohort composed of beneficiaries from the national cohort who were living in one of the CHS recruitment regions on January 1, 1993. We identified these beneficiaries by state and county of residence for the North Carolina, California, and Maryland regions. The Pennsylvania region was not county-based, so we used observed ZIP codes for CHS participants to select beneficiaries in that region. We limited the CHS cohort to participants who were alive on January 1, 1993 (the year of final recruitment of the second cohort) and could be matched to the Medicare denominator file (Fig. 1) .
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Comorbid Conditions
Data on comorbid conditions were available in the Medicare inpatient, outpatient, and carrier/physician files. All 3 files contain beneficiary identifiers and International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. 18 We identified comorbid conditions by using previously described coding algorithms. 19, 20 Specifically, we searched all claims generated in the calendar year before January 1, 1993, for evidence of myocardial infarction (ICD-9-CM codes 410. 
Resource Use and Costs
We obtained information on resource use and costs to Medicare in the calendar year before January 1, 1993. We characterized resource use as the mean number of inpatient stays, outpatient visits, medical evaluation and management visits, and cardiology evaluation and management visits per beneficiary. We defined an inpatient stay as an episode of inpatient care made up of overlapping or adjacent inpatient claims. We defined outpatient visits as distinct encounters in an outpatient institutional setting, limited to one outpatient visit per day. Medical evaluation and management visits were determined by Healthcare Common Procedure Coding System codes 21 992xx, 993xx, and 994xx in the physician/carrier claims file. Cardiology evaluation and management visits were determined by the specialty of the physician listed on the claim. Costs to Medicare are recorded as the reimbursement amounts on each claim (ie, paid claims, not charges). We report mean total costs, inpatient costs, outpatient costs, and physician costs per beneficiary. All costs are expressed in 1992 US dollars. For comparisons of resource use and costs, we selected only beneficiaries who were continuously enrolled in fee-for-service Medicare for one calendar year before January 1, 1993. Again, this restriction was necessary because comparisons of resource use and costs require data from claims that are not available for managed care enrollees.
Mortality
We compared all-cause mortality in the CHS cohort with both Medicare cohorts over a 10-year follow-up period. We obtained dates of death from the denominator files. To compare observed mortality rates, we included all beneficiaries from each cohort. To compare risk-adjusted rates, we only included beneficiaries from each cohort who had been continuously enrolled in fee-for-service Medicare for the entire year before January 1, 1993.
Statistical Analysis
As mentioned previously, the second phase of CHS recruitment targeted African American beneficiaries. As a result, the demographic distribution of the CHS cohort on January 1, 1993, is not the same as the demographic distribution of the Medicare population. Because our intent was to validate the CHS cohort, we applied weights to all Medicare beneficiaries so that the age, sex, and race distributions in the Medicare population reflected those in the CHS cohort. For weighting, we truncated age at 98 years for both the CHS cohort and the Medicare population. We created weights for each combination of age group (by year, range 65-98), sex (male or female), and race (black, white, or other/unknown). Of the 204 possible weighting groups, 144 were represented in the CHS cohort. Medicare beneficiaries in an unrepresented group were assigned a weight of zero. Weights for beneficiaries in other groups were calculated by dividing the proportion of the CHS cohort in each age, sex, and race group by the proportion of the Medicare population in the same group. For example, 70-year-old white men represented 2.6% of the CHS cohort and 2.1% of the Medicare population. Therefore, we assigned a weight of approximately 1.3 to 70-year-old white men in the Medicare data.
We describe demographic and administrative characteristics, comorbid conditions, resource use and costs, and mortality for the CHS cohort and both the national and regional Medicare cohorts. We present continuous variables as either medians with interquartile ranges or means with standard deviations. We present categorical variables as frequencies with percentages. We used a Kaplan-Meier estimator to calculate all-cause mortality at 1, 5, and 10 years for each cohort. We tested for differences between the CHS cohort and each Medicare cohort using t tests for continuous variables and 2 tests for categorical variables. We used a 
RESULTS
There were 5254 participants in the CHS cohort, 1,669,871 beneficiaries in the national Medicare cohort, and 10,075 beneficiaries in the regional Medicare cohort. Among persons enrolled continuously in fee-for-service Medicare in 1992, there were 4604 participants in the CHS cohort (88% of the total cohort), 1,306,957 beneficiaries in the national Medicare cohort (78%), and 6982 beneficiaries in the regional Medicare cohort (69%). Table 1 shows the demographic and administrative characteristics of the CHS cohort and the unweighted regional and national Medicare cohorts. The median age was 2 years greater in the CHS cohort than in either of the Medicare cohorts. The CHS cohort also had a higher proportion of men and African American participants and a much lower proportion of other races than the Medicare cohorts. After applying weights to the Medicare cohorts, the distributions of demographic characteristics were the same. All of the results that follow reflect calculations based on the weighted Medicare cohorts.
Compared with both Medicare cohorts, CHS participants were less likely to lack Medicare Part B coverage, to have a diagnosis of end-stage renal disease, to be concurrently enrolled in Medicaid, and to have been originally entitled to Medicare as a result of disability (Table 1) . CHS participants were more likely to be enrolled in Medicare managed care than beneficiaries in the national Medicare cohort but were less likely to be enrolled in a Medicare managed care plan than the regional Medicare cohort. The only CHS region with appreciable Medicare managed care enrollment was Sacramento County, California. We found higher enrollment in Medicare managed care among CHS participants (32%) than among Medicare beneficiaries (22%; P Ͻ 0.001).
For beneficiaries continuously enrolled in fee-for-service Medicare in 1992, Table 2 shows the percentage in each cohort with the listed comorbid conditions on any claim from 1992. Compared with the national Medicare cohort, CHS participants were significantly more likely to have had a prior myocardial infarction or to have been diagnosed with peripheral vascular disease, coronary heart disease, valvular heart disease, hypertension, or rheumatic disease. CHS participants were significantly less likely to have been diagnosed with congestive heart failure, stroke/transient ischemic attack, dementia, chronic pulmonary disease, or diabetes mellitus. Among all of these differences, however, only the proportion of patients with peripheral vascular disease and coronary heart disease were different by more than 2 percentage points between cohorts.
Compared with the regional Medicare cohort, CHS participants were significantly more likely to have been diagnosed with coronary heart disease but less likely to have been diagnosed with congestive heart failure, cerebrovascular disease, stroke/transient ischemic attack, dementia, or chronic obstructive pulmonary disease. Of these differences, only the proportion of patients with coronary heart disease and chronic obstructive pulmonary disease differed by more than 2 percentage points between cohorts.
Resource use and costs in each cohort in 1992 are shown in Table 3 . For almost all measures reported, the magnitude of differences between cohorts was small. In 1992, the CHS cohort had slightly fewer inpatient stays per bene- 
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Validity of the Cardiovascular Health Study ficiary compared with both Medicare cohorts. The CHS cohort had slightly more outpatient visits per beneficiary and slightly fewer medical evaluation and management visits than the regional Medicare cohort. The only resource use measure for which there was substantial variation was the mean number of cardiology evaluation and management visits. On average, CHS participants had about one additional visit as compared with beneficiaries in both of the Medicare cohorts.
Measures of costs did not differ between the CHS cohort and both of the Medicare cohorts. Figure 2 shows the mortality rate among all beneficiaries in each cohort. Over the 10-year period, the CHS cohort had markedly lower mortality than both of the Medicare cohorts. At 1 year, mortality in the CHS cohort was more than 40% lower (3.0% vs. 5.3% for the regional Medicare cohort and 5.3% for the national Medicare cohort). At 5 years, mortality was approximately 25% lower (19.7% vs. 26 .5% for the regional Medicare cohort and 25.9% for the national Medicare cohort). At 10 years, mortality was approximately 15% lower (43.1% vs. 51.0% for the regional Medicare cohort and 50.8% for the national Medicare cohort). Observed mortality in the CHS cohort was significantly different than observed mortality in both of the Medicare cohorts (P Ͻ 0.001). Observed mortality rates among beneficiaries who 
DiMartino et al
were continuously enrolled in Medicare fee-for-service in 1992 followed similar patterns ( Table 4 ). The hazard ratios of mortality for beneficiaries in the national and regional Medicare cohorts, compared with patients in the CHS cohort, were 0.78 (95% confidence interval, 0.75-0.82) and 0.74 (95% confidence interval, 0.70 -0.78), respectively. After adjustment for demographic characteristics and comorbid conditions, these hazard ratios were nearly unchanged.
CONCLUSIONS
This study compared the CHS cohort to national and regional cohorts of Medicare beneficiaries to assess the external validity of the CHS. Compared with both Medicare cohorts, the CHS cohort was older and had more men and African American participants. After weighting the Medicare cohorts so that the demographic distributions were identical to the CHS cohort, differences remained in administrative characteristics, comorbid conditions, resource use, and mortality. In general, the CHS cohort was healthier, less likely to be concurrently enrolled in Medicaid, and more likely to be enrolled in Medicare managed care. The CHS cohort also had lower mortality than both Medicare cohorts, and this disparity persisted during the 10-year follow-up period. The lower mortality rate in the CHS cohort persisted after risk adjustment.
Given the CHS recruitment strategy, the study protocol, and the potential for volunteer bias, the differences we observed are not unexpected. The CHS recruited noninstitutionalized, community-dwelling, Medicare-eligible individuals who were aged 65 or older as of 1989, the first year of CHS recruitment. There are several ways in which this recruitment strategy may be reflected in the differences we observed. First, the difference in age was expected because the recruitment strategy yielded a cohort in which the majority of CHS participants were aged 69 or older as of January 1, 1993. In comparison, both Medicare cohorts included beneficiaries who were aged 65 or older.
Second, the difference in Medicare managed care enrollment may reflect the recruitment of participants from Sacramento County, California. In the early 1990s, California was a leader in the penetration of Medicare-sponsored managed care plans. 22 For example, in 1993, California alone accounted for 40% of all Medicare managed care enrollees in the United States, and almost 20% of California's total Medicare population was enrolled in Medicare managed care. 22 Third, the finding that CHS participants were less likely to be diagnosed with dementia or stroke/transient ischemic attack may reflect the exclusion of persons who were unable to provide informed consent or communicate verbally during the baseline interview. The finding that CHS participants were less likely to be diagnosed with congestive heart failure may be due to underrepresentation of this diagnosis in the CHS, since congestive heart failure is common among persons living in nursing homes (who were excluded in the CHS). 23 Likewise, the lower mortality rate among CHS participants may reflect the exclusion of persons who were undergoing treatment for cancer, were confined to a wheelchair, or were in a hospice program. The exclusion of institutionalized persons in the CHS cohort may also explain this finding; however, the rate of institutionalized persons over age 65 in the United States is generally low and thus would not completely account for the consistently lower mortality rate in the CHS cohort during the 10-year follow-up period. 24 Fourth, another explanation for the lower mortality rate may be the proportion of participants enrolled in the CHS who were married (57.1% of women and 84.8% of men), which reflects higher marriage rates than among the general elderly population. 25 Although the majority of participants in the CHS were recruited from a randomly sampled Medicare eligibility list, 30% of participants were recruited from households of sampled participants, of whom more than 75% were spouses. 12 Marriage can be an important source of social support and has been shown to be associated with improved health status. 26, 27 Several studies have shown that persons who are married have a lower risk of mortality than those who are not married, even after adjustment for other factors. 27, 28 The finding that CHS participants had more cardiology evaluation and management visits per year may reflect the study protocol, which required participants to receive annual clinic examinations, particularly because there were few differences in mean physician costs per patient in the CHS cohort as compared with the Medicare cohorts. Specifically, CHS participants were referred from the annual clinic examination to a cardiologist if there was evidence of asymptomatic cardiovascular disease, "such as unstable angina, worsening congestive heart failure, uncontrolled hypertension . . . , or new onset transient ischemic attacks." 11 Lastly, volunteer bias (ie, those who volunteer may differ in certain ways from those who do not 29 ) may also provide an explanation for the lower mortality rate among CHS participants and some of the differences in comorbid conditions we observed. This may be particularly true in the comparison between the CHS cohort and the regional Medicare cohort, since this was the population from which CHS participants were originally sampled.
This study has some limitations. First, Medicare provides claims data for beneficiaries enrolled in fee-for-service care, not managed care. 30 Thus, we were unable to compare comorbid conditions and resource use for persons enrolled in managed care. Second, we cannot infer whether a beneficiary was institutionalized based on Medicare claims. As a result, we were unable to make a direct comparison between the noninstitutionalized CHS cohort and noninstitutionalized beneficiaries in the Medicare cohorts. However, a primary strength of this study is that it allowed for direct comparisons of the CHS cohort with the population from which it was initially drawn on both a national level and within the specific geographic regions sampled by the CHS. Furthermore, Medicare data provide a nationally representative sample of all patients aged 65 or older, and because Medicare data use standard individual identifiers, 31 we were able to match the CHS cohort with Medicare claims.
A final limitation is that we were not able to compare the entire initial CHS cohort with the Medicare population, because earlier Medicare claims data were not available. However, of the 5553 CHS participants alive at the 1992 to 1993 follow-up examination, 5254 (95%) could be matched to the Medicare denominator file and were used in this analysis.
The CHS is national resource of information without which data on risk factors for cardiovascular disease and stroke in the elderly population would be limited. In this analysis, we examined the external validity of the CHS to determine whether it is representative of Medicare beneficiaries nationally and of Medicare beneficiaries residing in the geographic regions sampled by the CHS. We found that the CHS cohort was comparable to the national and regional cohorts from which it was sampled with regard to comorbid conditions and resource use, but had lower mortality. These findings suggest that it may not be appropriate to project absolute rates of disease and outcomes based on CHS data to the entire Medicare population. However, there is no reason to expect that the relative risks of cardiovascular disease and events associated with physiologic processes identified in the CHS data would differ for nonparticipants.
